A Post-marketing Surveillance to Assess Safety and Efficacy of Rosuvatatin/Ezetimibe
Clinical trial NCT03648788 · UNKNOWN
Trial details
- NCT number
- NCT03648788
- Sponsor
- IlDong Pharmaceutical Co Ltd
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2018-09-01
- Primary completion
- 2024-06-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.